1.Sensory evoked potential and effect of SS-cream in premature ejaculation.
Zhong Cheng XIN ; Young Deuk CHOI ; Do Hwan SEONG ; Hyung Ki CHOI
Yonsei Medical Journal 1995;36(5):397-401
The cause of premature ejaculation (PE) has been thought to be psychological in the majority of patients but we investigated penile hypersensitivity for an organic basis of PE. For another organic basis of PE, we have suggested hyperexcitability of the ejaculation center. SS-cream is a topical agent containing 9 oriental herbs for treating PE. Clinically SS-cream has been effective in the treatment of PE. Therefore, in order to implicate the organic basis of PE and realize the effect of SS-cream on PE, we investigated the somatosensory evoked potential (SEP) in patients with PE(16 cases) and the effects of SS-cream on SEP for treating PE. The latencies and amplitudes of the evoked responses were measured by two different places in stimuli, one was on the penile shaft with ring electrode and the other on the glans penis with a surface electrode. The latency of SEP stimulated at the glans penis was significantly longer than that stimulated at the penile shaft (p< 0.05). The latency stimulated at the glans penis after applying SS-cream was significantly longer than before applying SS-cream (p< 0.05), which was near the level of a normal potent man. But the latency stimulated at the penile shaft has no significant difference between before and after the application of SS-cream (P > 0.05). The amplitudes of the evoked responses stimulated at the glans penis were significantly higher than those stimulated at penile shaft (p< 0.05). And both these amplitudes were significantly reduced with the application of SS-cream (p< 0.05). With these result, we can suggest that the patients with PE have glans penile hyperexcitability and it provides further implications for an organic basis of PE, SEP stimulated at the glans penis can be a very useful method to evaluate PE, along with SEP stimulated a penile shaft and SS-cream prolongs the sensory conduction and reduces the penile hyperexcitability of the patient with PE.
Adult
;
Drugs, Chinese Herbal/*therapeutic use
;
Ejaculation/*drug effects
;
Evoked Potentials, Somatosensory/*drug effects
;
Human
;
Male
;
Middle Age
;
Sexual Dysfunctions, Psychological/*drug therapy/physiopathology
2.Yohimbine in the treatment of orgasmic dysfunction.
Ade A ADENIYI ; Giles S BRINDLEY ; John P PRYOR ; David J RALPH
Asian Journal of Andrology 2007;9(3):403-407
AIMTo study the effect of yohimbine in the treatment of men with orgasmic dysfunction.
METHODSA 20-mg dose of yohimbine was first given to 29 men with orgasmic dysfunction of different aetiology in the clinic. Patients were then allowed to increase the dose at home (titration) under more favourable circumstances. The outcome and side effects were subsequently assessed.
RESULTSThe patients were classified into three groups of orgasmic dysfunction: primary complete (13), primary incomplete (8) and secondary (8). Nocturnal emissions were present in 75%, 40% and 50% of patients in the above groups, respectively (overall average 62%). The men presented because of fertility problems (52%) or because they wanted to experience the pleasure of orgasm (48%). Of the 29 patients who completed the treatment, 16 managed to reach orgasm and were able to ejaculate either during masturbation or sexual intercourse. A further three achieved orgasm, but only with the additional stimulation of a vibrator. A history of preceding nocturnal emissions was present in 69% of the men in whom orgasm was induced but only 50% who failed treatment. Of the patients, two have subsequently fathered children (one set of twins) and another 3 men were also cured. Side effects were not sufficient to cause the men to cease treatment.
CONCLUSIONYohimbine is a useful treatment option in orgasmic dysfunction.
Adrenergic alpha-Antagonists ; therapeutic use ; Adult ; Aged ; Dose-Response Relationship, Drug ; Ejaculation ; drug effects ; physiology ; Humans ; Male ; Middle Aged ; Sexual Dysfunctions, Psychological ; drug therapy ; physiopathology ; Treatment Outcome ; Yohimbine ; therapeutic use